BUSINESS
Cipla gains on receiving USFDA’s final approval for Sumatriptan Nasal Spray
Cipla is currently trading at Rs. 800.10, up by 10.60 points or 1.34% from its previous closing of Rs. 789.50 on the…
Cipla is currently trading at Rs. 800.10, up by 10.60 points or 1.34% from its previous closing of Rs. 789.50 on the…
Cipla is currently trading at Rs. 807.40, up by 1.85 points or 0.23% from its previous closing of Rs. 805.55 on the…
Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets 450mg from the United States Food and…
Cipla’s wholly owned subsidiary — Cipla Medpro South Africa (Pty) has completed the acquisition of 100% stake in Mirren (Pty) on October…